Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Because the company's website is here................
http://imdcompaniesinc.com
It's been up and running for a while.
Per the ICANN database, this domain was created on Nov 4, 2016 and registered by Guy Phillips, who appears to be the owner of Impact Web Solutions, LLC. In short, looks like ICBU paid to have a new website built last November and this is the new domain to use moving forward.
I finally had a chance to read through Algrosolutions, LLC v. The Automotive Resource Network Holdings et al. Sounds like ARNH was essentially just released from liability of a $60K convertible note with 12% interest dating back to July of 2012.
Anyone know or predict any additional consequences of this? Or perhaps just a case of the plaintiff realizing the company was already under water with nothing left to make payments, and any further battles in court would be a waste of time and money?
Agree. Seems like every week lately we reach high $12's and it bounces right back to the middle. I'm patient. In the meantime, it's easy to look at Ford like a bond paying nearly 5% annually.
Aurora and Canopy Growth are about 4% in the red today too. So, this is probably just the market tugging Organigram down today.
You're right and I misread the chart and sounded the war horn way to early anyway. Thought a trade just went through at 0.0001. Nope. So far, so good.
Ewww. Not looking so hot. Bid back to rock bottom 1's.
I cannot wait to hear what those new business "oppertunities" are lol!
Right, I almost hope they do. Just look at what it's done for OWCP and even RSII. Pure rocket ships.
Definitely oversold at these levels, but if it breaks down into the low $1.80's (OGRMF), then we have a problem with support cracking. I still think this is going to correct itself, but breaking $1.80 could send this a lot deeper and it's not a short-term game I'm going to play. Long term, either way, it's going places. Just not sure of the timeline yet.
Probably jumping in the marijuana industry like everyone else lol. Would not surprise me one bit.
Thanks, couldn't get any of the links to work, but searching for the case did the trick!
ROFL I just slapped the ask. I was going to visit the casino tonight with my colleague and he had to bail. This looks more fun and probably has better odds of turning into something than the way I play roulette.
Good luck everyone :)
I, for one, sincerely thank you and JLUT for spending so much time on not only completing DD but also communicating your findings to the board. Of course, everyone is encouraged to do their own fact checking and follow-up DD, but this still saves me (and likely others) time. Much appreciated and keep up the great work!
Agree, this board is turning around and becoming valuable. Great DD and explanations being posted all around. Thanks.
USD to CAD is about 1.32 right now, so for example, if CSE trading were to resume now, it would start trading at about 0.1525 (ATTBF in USD) * 1.32 (Currency multiplier) = about 0.20 Canadian.
Well, I wouldn't be surprised if Abattis draws more attention to the drama surrounding Mettrum and Organigram with myclobutanil contamination. As a result of this, HC has even declared that random testing for pesticides and other harmful materials would soon be introduced to all LP's in the industry.
I don't have the Mettrum numbers handy, but as an OGI investor, I know the ensuing recall cost Organigram $2.26 million. And now all consumer eyes are especially drawn to the safety of the products they are consuming.
ATTBF on the U.S. OTCQB is trading and finished about +13%, yes.
However, ATT on the CSE is still suspended:
http://thecse.com/en/listings/life-sciences/abattis-bioceuticals-corp
And I'm curious on other's opinions here, but I'd think Abattis would issue a PR on the day CSE resumes trading for ATT. Expecting something by end of the week.
I also thought they acted and responded as best they could, given the circumstances. A little disappointed the stock is lagging behind, but will give it some time.
No, I'm not sure what's confusing you at this point. The financials are filed and posted for you, me, and the world to read. The very first page (beyond the cover page) of that report in the link I provided includes the Independent Auditor's Report:
http://www.otcmarkets.com/financialReportViewer?symbol=ATTBF&id=166839
Filing the report and resuming trading on the CSE again are two different events. Now that the financials are filed, it's expected to take a few business days before CSE reviews them and removes the suspension.
The company didn't specifically say in any PR that "The 2016 annual report has been filed," if that's what you're looking for. But if you check ATTBF on OTC Markets, for example, you'll note they were filed last Friday.
The 2016 annual report for ATTBF and other filings are available at OTC Markets:
http://www.otcmarkets.com/stock/ATTBF/filings
You can find that specific report at this link:
http://www.otcmarkets.com/financialReportViewer?symbol=ATTBF&id=166839
Weird action today. The price is kind of plopping all over the place. But why should I expect anything different with this stock? :)
It was pretty obvious that once the low 20's struggled to hold up that NTCXF didn't have much supporting it above the teens. And yes, that's exactly what I declared I was going to do weeks ago. Wait until the teens, see how low it goes, and if I deem the stock worthy of re-entry, be able to purchase 50-100% more of the stock for the same price I previously sold.
ebota, how much have you really looked into this? I'm just curious if you're familiar with microbial and cannabinoid testing? I really would like to hear more about the feasibility (or unlikelihood) of ATTBF ever posting 7 figure revenue numbers from NV at some point in their future. From what I've found online, the cost of a single sample exceeds $100, sometimes even closer to $200, especially if you require expedited services. And although the market will take time to grow, eventually licensed producers may have dozens of samples to test on a very regular basis. At least, it sounds like HC will require very regular testing, from the final report of the Task Force on Cannabis Legalization and Regulation submitted in Nov 2016.
Because it's important to keep track of this, let's look at O/S, etc. for ATTBF, per the latest filing (up to 9/30/16).
Outstanding Shares: 111,760,004
Outstanding Warrants: 21,019,989
Stock Options: 6,410,000
So, to be conservative, you can assume 139,189,993 shares when calculating valuation.
And as I've said before, if you want to be extra conservative, assume at least 150 to 200M O/S or equivalents by the time the company starts producing meaningful revenue. Even figuring valuation at 200M, I think you'll find ATTBF has plenty of room to spring higher when comparing it to other stocks in this sector.
Ugh, not going to lie. It hurts a little to see a former Abattis officer and the name "Bill Chaaban," among other Creative Edge clowns, listed in a comparison table.
Same, and as long as trading resumes on the CSE by the end of next week, I don't care. Just want them to get the monkey off their back.
Not yet. Looking from Tues-Fri, most cases in penny land when you see a pop like that, by Friday it would be down to at least 0.04, or i.e. about a 50% retracement from the absolute peak. It's holding up a little better than most, but I'd rather wait and see what happens Monday first. GL.
Zason, I remember when Mike tweeted in response to an aggressive Abattis investor in mid 2014 that if ATTBF ever went to a nickel, he'd essentially buy it outright, because it'd be a steal. So much for that talk. I've never been fully clear on what he brought to the table. Maybe a little experience and influence. It may have been his idea to spin the diversification method and throw darts all over the place in this industry, hoping just one would hit the bullseye. I don't know.
I do know it looks like we may finally be plotting a straight course for the right direction, and perhaps that's all that matters anymore.
It is looking like the 0.12 range may return, yes. I sold off in the 0.21's and won't bother re-entering until there's a clear bottom. GLTA.
Holding on from my doubled position last week at 1.98. The industry got spooked today, but this could easily turn around by Monday.
Thanks, I was planning on looking into Dr. Otiko's online reputation tonight, and this was a great head-start. It does look pretty good, for starters. In fact, the only extremely negative review on Yelp was from someone that was mad because the office staff speaks Arabic amongst themselves, then wasn't entirely pleased with "one of the doctors" in the office (we don't even know who).
Bid back above 0.14. A small victory, but I'll take it. Wonder how close to 3M volume we'll get today.
That was part of the reason I stayed, and also because the industry itself was enjoying a nice boost. I'd still have a pretty thick cloud of anxiety over my head right now if I were short. I'll give you that.
tomadam, I don't like the silent phones either. But it is a small company with few employees, and they are rushing to fix financial reporting shortcomings. You have testimony from other investors (if not here, on other boards.. I forget) from a couple weeks ago, in which they did talk to Abattis IR about the filing status. When they get things rolling again, yes, I hope they commit to having someone ready to take investor's questions on a more consistent basis.
That said, if you're going to call this a pump and dump based on the single fact that you couldn't get through when you called, I don't think this warrants further debate. It's like to trying to convict a shopper of stealing something because you saw him with one hand placed in his pocket as he walked out the door. Poor evidence on its own.
This hit 0.15 a bit faster than I was expecting. Sure looks like it's going to test those Dec 2016 lows.
It's a company with good potential IMHO, but has yet to prove itself as a good company. I didn't dump my 3 year core position in the 0.20's when I could have, because in theory, the valuation is still extremely low and I do believe this can shoot a lot higher with more market awareness and an improved reputation. But I'll tell you what... the end result of this sloppy financial blunder will give me a strong push in one direction. Jump ship or re-commit.
Well look at that! You were right :)